SCHEMBL2841122

SCHEMBL2841122

CN1Cc2ccsc2C(Oc2cccc([N+](=O)[O-])c2)C1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 1/20 0.41
SLC6A4 P31645 1/20 0.41
SLC6A3 Q01959 1/20 0.41
CHRNB4 P30926 1/20 0.41
CHRNA3 P32297 1/20 0.41
CHRNB2 P17787 2/20 0.36
CHRNA4 P43681 2/20 0.36
LTA4H P09960 1/20 0.36
PTGS2 P35354 1/20 0.36
MAPT P10636 4/20 0.36
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
EGFR P00533 1/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
BCL2A1 Q16548 1/20 0.35
PKM P14618 1/20 0.35
MAPK1 P28482 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2840442 0.83 SLC6A2 (0.45) SLC6A2SLC6A4SLC6A3CHRNB4CHRNA3
Hydrochloric Acid SCHEMBL2840961 0.80 SLC6A2 (0.39) SLC6A2SLC6A4SLC6A3KMT2A
Hydrochloric Acid SCHEMBL2840796 0.73 SLC6A2 (0.41) SLC6A2SLC6A4SLC6A3CHRNB4CHRNA3
Hydrochloric Acid SCHEMBL2844211 0.73 SLC6A2 (0.40) SLC6A2SLC6A4SLC6A3
SCHEMBL374672 0.71 SLC6A2 (0.60) SLC6A2SLC6A4SLC6A3CHRNB4CHRNA3
SCHEMBL25335598 0.70 SLC6A2 (0.59) SLC6A2SLC6A4SLC6A3CHRNB4CHRNA3
SCHEMBL25336072 0.69 SLC6A2 (0.57) SLC6A2SLC6A4SLC6A3CHRNB4CHRNA3
Hydrochloric Acid SCHEMBL2841676 0.69 SLC6A2 (0.39) SLC6A2SLC6A4SLC6A3ALDH1A1
SCHEMBL25336074 0.69 SLC6A2 (0.56) SLC6A2SLC6A4SLC6A3CHRNB4CHRNA3
SCHEMBL7057566 0.68 CHRNB4 (0.57) SLC6A2SLC6A4SLC6A3CHRNB4CHRNA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8217031-B2 Heteroaryl derivatives NIPPON SHINYAKU CO., LTD. (JP) 2012-07-10 US disclosed
US-20100048537-A1 HETEROARYL DERIVATIVES NIPPON SHINYAKU CO., LTD. (JP) 2010-02-25 US disclosed
EP-2141168-A1 HETEROARYL DERIVATIVES Nippon Shinyaku Co., Ltd. (JP) 2010-01-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048537-A1 HETEROARYL DERIVATIVES OPRD1, OPRM1, OPRK1 SLC6A2 196/4885SLC6A4 185/4885SLC6A3 118/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.